EMA Updates Clinical Requirements in Adult, Pediatric Heart Failure Trials

Wednesday, June 17, 2015

Source: FDANEWS

The European Medicines Agency released final guidance on the primary and secondary endpoints sponsors should use to evaluate drugs to treat acute heart failure — along with recommendations on designing and conducting such studies in children.

View All News »